Bexarotene

TSPY like 2 ; Homo sapiens







64 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 14686975 Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma. 2003 3
52 15202526 Overview of cutaneous T-cell lymphoma: prognostic factors and novel therapeutic approaches. 2003 2
53 11902983 Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma. 2002 Mar 2
54 11978140 Treatment of cutaneous T cell lymphoma: current status and future directions. 2002 2
55 12006543 Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. 2002 May 5
56 12399758 Optimizing bexarotene therapy for cutaneous T-cell lymphoma. 2002 Nov 2
57 12847736 Treatment of mycosis fungoides with oral bexarotene combined with PUVA. 2002 Sep 1
58 11331325 Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. 2001 May 1 1
59 11520254 Therapeutic advances in biological response modifiers in the treatment of cutaneous T-cell lymphoma. 2001 1
60 11573857 Oral bexarotene in the treatment of cutaneous T-cell lymphoma. 2001 Sep 5
61 11705358 Cutaneous T-cell lymphoma. New immunomodulators. 2001 Oct 1
62 11249708 Bexarotene ligand pharmaceuticals. 2000 Dec 2
63 11702369 Bexarotene. 2000 Jul-Aug 2
64 11707864 The treatment of cutaneous T-cell lymphoma with a novel retinoid. 2000 Nov 2